Personalized Medicine Conference Archives - Slone Partners

In: Personalized Medicine Conference

Dr. Carl June

PMC Series: Interview with Dr. Carl June, Richard W. Vague Professor in Immunotherapy, Director of the Center for Cellular Immunotherapies, Perelman School of Medicine at University of Pennsylvania

Dr. Carl June is the Richard W. Vague Professor in Immunotherapy and Director of the Center for Cellular Immunotherapies at the Perelman School of...

PMC Series: Interview with Anne-Marie Martin, Ph.D., SVP and Global Head of Precision Medicine at Novartis Pharmaceuticals Corporation

As part of Slone Partners’ 2019 PMC Interview Series, we are delighted to present an exclusive interview with Anne-Marie Martin, Ph.D.,...

Kenna Shaw

PMC Series: Interview with Kenna R. Shaw, Ph.D., Executive Director of Khalifa Institute for Personalized Cancer Therapy and Cancer Genomics Laboratory, MD Anderson Cancer Center

Kenna R. Mills Shaw, Ph.D., is the Executive Director of the Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer...

PMC Series: Interview with Mark P. Stevenson, Executive Vice President and Chief Operating Officer of Thermo Fisher Scientific

Kicking off Slone Partners’ 2019 PMC Interview Series, we are proud to present an exclusive discussion with Mark P. Stevenson, Executive...

PMC Series: Interview with Bryce Olson, Global Strategist, Health and Life Sciences, Intel Corporation

Slone Partners’ 2018 PMC Interview Series concludes with an exclusive, in-depth interview with Bryce Olson, a Global Strategist at Intel Corporation’s...

PMC Series: Interview with Colin Hill, Chairman, CEO and Co-Founder of GNS Healthcare

Slone Partners’ 2018 PMC Interview Series enters its 4th week with an exclusive, in-depth interview with Colin Hill, the Chairman, CEO...

PMC Series: Interview with William Dalton, Ph.D M.D., Founder and Executive Chair of M2Gen

Slone Partners’ 2018 PMC Interview Series continues with an exclusive, in-depth interview with William Dalton Ph.D M.D., the Founder and Executive...

PMC Series: Interview with David King, Chairman and CEO of LabCorp

Slone Partners’ 2018 PMC Interview Series continues with an exclusive, in-depth interview with David P. King, the Chairman and CEO of...

PMC Series: Interview with Daniel O’Day, CEO of Roche Pharmaceuticals

Slone Partners’ 2018 PMC Interview Series debuts with an exclusive, in-depth interview of Daniel O’Day, the CEO of Roche Pharmaceuticals. A...